Home›Companies›Biotech & Pharma›Lighthouse Pharma

Lighthouse Pharmaceuticals, Inc.

Develops experimental medicines for people with neurodegenerative and inflammatory diseases.

Updated Nov 10, 2026·Latest SEC filing May 7, 2026·Suggest an edit

About Lighthouse Pharma

Lighthouse Pharma is a private company based in Novato, California, incorporated in 2022 in Delaware. It has reported $15,206,800 raised in one offering on Form D since May 2026. Its chief executive is Casey Lynch.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 22, 2026May 7, 2026$15,206,800fully sold25$608KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Lighthouse Pharma's Form D filed May 7, 2026.

CL
Casey Lynch
Chief Executive Officer and director
Also an executive officer at ACP Investment.

Sources

  1. SECLighthouse Pharmaceuticals, Inc. filing history
  2. PressLighthouse Pharmaceuticals Series A announcement